Cytologically Negative Carcinomatous Meningitis:Usefulness of CSF Biochemical Markers
Neurol 50:1173-1175, Chamberlain,M.C., 1998
The Value of Interphase Cytogenetics in Cytology for the Diagnosis of Leptomeningeal Metastases
Neurol 51:906-908, Van Oostengrugge,R.J.,et al, 1998
Leptomeningeal Carcinomatosis:Presenting Features and Prognostic Factors
Arch Neurol 53:626-632, Balm,M.&Hammack,J., 1996
Glucosephosphate Isomerase as a CSF Marker for Leptomeningeal Metastasis
Neurol 41:395-398, Newton,H.B.,et al, 1991
Neoplastic Meningitis in Malignant Melanoma:Diagnosis with Monoclonal Antibodies
JNNP 52:881-886, Moseley,R.P.,et al, 1989
Use of Monoclonal Antibody Panel to Identify Malignant Cells in Cerebrospinal Fluid
Lancet 1:1095-1098, Coakham,H.B.,et al, 1984
CSF Carcinoembryonic Antigen in Meningeal Carcinomatosis From Breast Cancer
JAMA 244:1601-1603, Yap,B-S.,et al, 1980
CSF B-Glucoronidase Assay in the Diagnosis of Neoplastic Meningitis
Arch Neurol 37:684-687, Shuttleworth,E.,et al, 1980
Diagnosis of Leukemia Or Lymphoma In The Central Nervous System by Beta-Microglobulin Determination
NEJM 303:718-722, Mavligit,G.M.,et al, 1980
Cerebrospinal Fluid Biochemical Markers of Central Nervous System Metastases
Ann Neurol 8:597-604, Schold,S.C.,et al, 1980
Central Nervous System Germinomas, A Review
Arch Neurol 48:652-657, Horowitz,M.B.&Hall,W.A., 1991